HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Crossreaction of monoclonal anti-T-cell antibodies: implications for classifying B-cell leukemias.

Abstract
Cell samples from 62 patients with B-cell leukemias (33 CLL, 8 IC, 6 PLL, 4 HCL, 2 ALL and 9 other NHL) were tested with a series of monoclonal antibodies (A50, T101, Lyt2, Leu 1, M203) directed against T cells and shown to crossreact with B-CLL. The results demonstrate a heterogeneity of B-cell leukemias as all typical cases of CLL were reactive whereas most other cases were negative. Using the fluorescence-activated cell sorter, a somewhat stronger reaction was seen in early or benign cases of CLL, compared to advanced cases. All B-cell leukemias tested expressed the Ia antigen.
AuthorsR Munker, E Thiel, U Kummer, H Rodt, S Thierfelder
JournalBlut (Blut) Vol. 46 Issue 2 Pg. 95-100 (Feb 1983) ISSN: 0006-5242 [Print] Germany
PMID6600407 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
Topics
  • Adult
  • Aged
  • Antibodies, Monoclonal (immunology)
  • B-Lymphocytes (immunology)
  • Cross Reactions
  • Female
  • Humans
  • Leukemia, Hairy Cell (immunology)
  • Leukemia, Lymphoid (classification, immunology)
  • Lymphoma (immunology)
  • Male
  • Middle Aged
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: